H Iwase1, B Ekser2, V Satyananda1, H Zhou3, H Hara1, P Bajona1, M Wijkstrom1, J K Bhama4, C Long1, M Veroux5, Y Wang6, Y Dai7, C Phelps7, D Ayares7, M B Ezzelarab1, D K C Cooper8. 1. Thomas E Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, PA, USA. 2. Thomas E Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, PA, USA; Department of Surgery, Transplantation and Advanced Technologies, Vascular Surgery and Organ Transplant Unit, University Hospital of Catania, Catania, Italy. 3. Thomas E Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, PA, USA; Center for Kidney Transplantation, Second Affiliated Hospital of the University of South China, Hengyang, Hunan, China. 4. Department of Cardiac Surgery, University of Pittsburgh, Pittsburgh, PA, USA. 5. Department of Surgery, Transplantation and Advanced Technologies, Vascular Surgery and Organ Transplant Unit, University Hospital of Catania, Catania, Italy. 6. Center for Kidney Transplantation, Second Affiliated Hospital of the University of South China, Hengyang, Hunan, China. 7. Revivicor, Blacksburg, VA, USA. 8. Thomas E Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, PA, USA. Electronic address: cooperdk@upmc.edu.
Abstract
BACKGROUND: In the pig-to-nonimmunosuppressed baboon artery patch model, a graft from an α1,3-galactosyltransferase gene-knockout pig transgenic for human CD46 (GTKO/CD46) induces a significant adaptive immune response (elicited anti-pig antibody response, increase in T cell proliferation on MLR, cellular infiltration of the graft), which is effectively prevented by anti-CD154mAb-based therapy. METHODS: As anti-CD154mAb is currently not clinically applicable, we evaluated whether it could be replaced by CD28/B7 pathway blockade or by blockade of both pathways (using belatacept + anti-CD40mAb [2C10R4]). We further investigated whether a patch from a GTKO/CD46 pig with a mutant human MHC class II transactivator (CIITA-DN) gene would allow reduction in the immunosuppressive therapy administered. RESULTS: When grafts from GTKO/CD46 pigs were transplanted with blockade of both pathways, a minimal or insignificant adaptive response was documented. When a GTKO/CD46/CIITA-DN graft was transplanted, but no immunosuppressive therapy was administered, a marked adaptive response was documented. In the presence of CD28/B7 pathway blockade (abatacept or belatacept), there was a weak adaptive response that was diminished when compared with that to a GTKO/CD46 graft. Blockade of both pathways prevented an adaptive response. CONCLUSION: Although expression of the mutant MHC CIITA-DN gene was associated with a reduced adaptive immune response when immunosuppressive therapy was inadequate, when blockade of both the CD40/CD154 and CD28/B7 pathways was present, the response even to a GTKO/CD46 graft was suppressed. This was confirmed after GTKO/CD46 heart transplantation in baboons.
BACKGROUND: In the pig-to-nonimmunosuppressed baboon artery patch model, a graft from an α1,3-galactosyltransferase gene-knockout pig transgenic for humanCD46 (GTKO/CD46) induces a significant adaptive immune response (elicited anti-pig antibody response, increase in T cell proliferation on MLR, cellular infiltration of the graft), which is effectively prevented by anti-CD154mAb-based therapy. METHODS: As anti-CD154mAb is currently not clinically applicable, we evaluated whether it could be replaced by CD28/B7 pathway blockade or by blockade of both pathways (using belatacept + anti-CD40mAb [2C10R4]). We further investigated whether a patch from a GTKO/CD46pig with a mutant humanMHC class II transactivator (CIITA-DN) gene would allow reduction in the immunosuppressive therapy administered. RESULTS: When grafts from GTKO/CD46pigs were transplanted with blockade of both pathways, a minimal or insignificant adaptive response was documented. When a GTKO/CD46/CIITA-DN graft was transplanted, but no immunosuppressive therapy was administered, a marked adaptive response was documented. In the presence of CD28/B7 pathway blockade (abatacept or belatacept), there was a weak adaptive response that was diminished when compared with that to a GTKO/CD46 graft. Blockade of both pathways prevented an adaptive response. CONCLUSION: Although expression of the mutant MHC CIITA-DN gene was associated with a reduced adaptive immune response when immunosuppressive therapy was inadequate, when blockade of both the CD40/CD154 and CD28/B7 pathways was present, the response even to a GTKO/CD46 graft was suppressed. This was confirmed after GTKO/CD46 heart transplantation in baboons.
Authors: A D Griesemer; A Hirakata; A Shimizu; S Moran; A Tena; H Iwaki; Y Ishikawa; P Schule; J S Arn; S C Robson; J A Fishman; M Sykes; D H Sachs; K Yamada Journal: Am J Transplant Date: 2009-10-21 Impact factor: 8.086
Authors: I R Badell; P W Thompson; A P Turner; M C Russell; J G Avila; J A Cano; J M Robertson; F V Leopardi; E A Strobert; N N Iwakoshi; K A Reimann; M L Ford; A D Kirk; C P Larsen Journal: Am J Transplant Date: 2011-09-15 Impact factor: 8.086
Authors: Tadatsura Koshika; Carol Phelps; Jason Fang; Seung Eun Lee; Minoru Fujita; David Ayares; David K C Cooper; Hidetaka Hara Journal: Immunology Date: 2011-12 Impact factor: 7.397
Authors: Hidetaka Hara; Naoko Koike; Cassandra Long; Jordan Piluek; Danny S Roh; Nirmala SundarRaj; James L Funderburgh; Yoshiaki Mizuguchi; Kumiko Isse; Carol J Phelps; Suyapa F Ball; David L Ayares; David K C Cooper Journal: Invest Ophthalmol Vis Sci Date: 2011-07-15 Impact factor: 4.799
Authors: F Vincenti; B Charpentier; Y Vanrenterghem; L Rostaing; B Bresnahan; P Darji; P Massari; G A Mondragon-Ramirez; M Agarwal; G Di Russo; C-S Lin; P Garg; C P Larsen Journal: Am J Transplant Date: 2010-03 Impact factor: 8.086
Authors: T Aoyagi; K Yamashita; T Suzuki; M Uno; R Goto; M Taniguchi; T Shimamura; N Takahashi; T Miura; K Okimura; T Itoh; A Shimizu; H Furukawa; S Todo Journal: Am J Transplant Date: 2009-06-10 Impact factor: 8.086
Authors: D J van der Windt; R Bottino; A Casu; N Campanile; C Smetanka; J He; N Murase; H Hara; S Ball; B E Loveland; D Ayares; F G Lakkis; D K C Cooper; M Trucco Journal: Am J Transplant Date: 2009-10-21 Impact factor: 8.086
Authors: Carol J Phelps; Suyapa F Ball; Todd D Vaught; Amy M Vance; Michael Mendicino; Jeffrey A Monahan; Anneke H Walters; Kevin D Wells; Amy S Dandro; Jagdeece J Ramsoondar; David K C Cooper; David L Ayares Journal: Xenotransplantation Date: 2009 Nov-Dec Impact factor: 3.907
Authors: Mohamed Ezzelarab; Bertha Garcia; Agnes Azimzadeh; Hongtao Sun; Chih Che Lin; Hidetaka Hara; Sean Kelishadi; Tianshu Zhang; Yih Jyh Lin; Hao-Chi Tai; Robert Wagner; Jnanesh Thacker; Noriko Murase; Kenneth McCurry; Rolf N Barth; David Ayares; Richard N Pierson; David K C Cooper Journal: Transplantation Date: 2009-03-27 Impact factor: 4.939
Authors: Tao Li; Whayoung Lee; Hidetaka Hara; Cassandra Long; Mohamed Ezzelarab; David Ayares; Hai Huang; Yi Wang; Charles T Esmon; David K C Cooper; Hayato Iwase Journal: Transplantation Date: 2017-10 Impact factor: 4.939
Authors: Hayato Iwase; Burcin Ekser; Vikas Satyananda; Jay Bhama; Hidetaka Hara; Mohamed Ezzelarab; Edwin Klein; Robert Wagner; Cassandra Long; Jnanesh Thacker; Jiang Li; Hao Zhou; Maolin Jiang; Santosh Nagaraju; Huidong Zhou; Massimiliano Veroux; Pietro Bajona; Martin Wijkstrom; Yi Wang; Carol Phelps; Nikolai Klymiuk; Eckhard Wolf; David Ayares; David K C Cooper Journal: Xenotransplantation Date: 2015-04-03 Impact factor: 3.907
Authors: Hayato Iwase; Burcin Ekser; Huidong Zhou; Hong Liu; Vikas Satyananda; Rishab Humar; Pooja Humar; Hidetaka Hara; Cassandra Long; Jay K Bhama; Pietro Bajona; Yi Wang; Martin Wijkstrom; David Ayares; Mohamed B Ezzelarab; David K C Cooper Journal: Xenotransplantation Date: 2015-08-21 Impact factor: 3.907
Authors: Takayuki Yamamoto; Qi Li; Hidetaka Hara; Liaoran Wang; Hongmin Zhou; Juan Li; Devin E Eckhoff; A Joseph Tector; Edwin C Klein; Ray Lovingood; Mohamed Ezzelarab; David Ayares; Yi Wang; David K C Cooper; Hayato Iwase Journal: Transpl Immunol Date: 2018-08-06 Impact factor: 1.708
Authors: David K C Cooper; Shinichi Matsumoto; Adrian Abalovich; Takeshi Itoh; Nizar I Mourad; Pierre R Gianello; Eckhard Wolf; Emanuele Cozzi Journal: Transplantation Date: 2016-11 Impact factor: 4.939
Authors: Hayato Iwase; Hong Liu; Eva Schmelzer; Mohamed Ezzelarab; Martin Wijkstrom; Hidetaka Hara; Whayoung Lee; Jagjit Singh; Cassandra Long; Eric Lagasse; Jörg C Gerlach; David K C Cooper; Bruno Gridelli Journal: Xenotransplantation Date: 2017-01-28 Impact factor: 3.907